Development and Validation of a Digital Analysis Method to Quantify CD3-immunostained T Lymphocytes in Whole Slide Images of Crohn's Disease Biopsies
- PMID: 35587994
- DOI: 10.1097/PAI.0000000000001035
Development and Validation of a Digital Analysis Method to Quantify CD3-immunostained T Lymphocytes in Whole Slide Images of Crohn's Disease Biopsies
Abstract
The T-lymphocyte-mediated inflammation in Crohn's disease can be assessed by quantifying CD3-positive T-lymphocyte counts in colonic sections. We developed and validated a process to reliably quantify immunohistochemical marker-positive cells in a high-throughput setting using whole slide images (WSIs) of CD3-immunostained colonic and ileal tissue sections. In regions of interest (ROIs) and/or whole tissue sections of 40 WSIs from 36 patients with Crohn's disease, CD3-positive cells were quantified by an expert gastrointestinal pathologist (gold standard) and by image analysis algorithms developed with software from 3 independent vendors. Semiautomated quantification of CD3-positive cell counts estimated in 1 ROI per section were accurate when compared with manual analysis (Pearson correlation coefficient, 0.877 to 0.925). Biological variability was acceptable in digitally determined CD3-positive cell measures between 2 to 5 ROIs annotated on the same tissue section (coefficient of variation <25%). Results from computer-aided analysis of CD3-positive T lymphocytes in a whole tissue section and the average of results from 2 to 5 ROIs per tissue section lacked reliability (overestimation or underestimation and systematic bias), suggesting that absolute quantification of CD3-positive T lymphocytes in a whole tissue section may be more accurate. Semiautomated image analysis in WSIs demonstrated reproducible CD3-positive cell measures across 3 independent algorithms. A computer-aided digital image analysis method was developed and validated to quantify CD3-positive T lymphocytes in colonic and ileal biopsy sections from patients with Crohn's disease. Results support consideration of this digital analysis method for use in future Crohn's disease clinical studies.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Hammoud L, Adams JR, Loch AJ, et al. Identification of RSK and TTK as modulators of blood vessel morphogenesis using an embryonic stem cell-based vascular differentiation assay. Stem Cell Reports. 2016;7:787–801.
-
- Duan K, Sowamber R, McKee TD, et al. Quantitative assessment of the immune microenvironment in ovarian cancer: a comparison of two digital imaging platforms [abstract 1137]. Lab Investig. 2017;97:283A.
-
- US Food and Drug Administration. 510(k) Substantial equivalence determination decision summary (computer-assisted image analyzer for Ki-67 nuclear protein immunohistochemistry); 2006. Available at: www.accessdata.fda.gov/cdrh_docs/reviews/K053520.pdf . Accessed April 9, 2021.
-
- US Food and Drug Administration. 510(k) Substantial equivalence determination decision summary (computer-assisted image analyzer for immunohistochemistry; Her2/neu protein on formalin-fixed paraffin-embedded breast cancer specimens); 2007. Available at: www.accessdata.fda.gov/cdrh_docs/reviews/K031715.pdf . Accessed April 9, 2021.
-
- Ventana Medical Systems and Roche Diagnostics International. VENTANA PD-L1 (SP142) assay scoring algorithm - urothelial carcinoma. [VENTANA PD-L1 (SP142) Assay Interpretation Guide for Urothelial Carcinoma]; 2020. Available at: https://diagnostics.roche.com/content/dam/diagnostics/us/en/products/v/v... . Accessed April 9, 2021.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical